2023
DOI: 10.1016/j.jceh.2022.12.006
|View full text |Cite
|
Sign up to set email alerts
|

Alcohol-Associated Liver Disease – From Pathogenesis to Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Patients with ALD and cirrhosis develop acute alcohol-associated hepatitis (AH), which has the highest mortality (5,6). Despite extensive research and clinical trials, there is no FDA-approved therapy for any stage of ALD (7)(8)(9). Previous research has shown that c-Jun N-terminal kinase (JNK) plays a significant role in hepatocyte death (10)(11)(12).…”
Section: Introductionmentioning
confidence: 99%
“…Patients with ALD and cirrhosis develop acute alcohol-associated hepatitis (AH), which has the highest mortality (5,6). Despite extensive research and clinical trials, there is no FDA-approved therapy for any stage of ALD (7)(8)(9). Previous research has shown that c-Jun N-terminal kinase (JNK) plays a significant role in hepatocyte death (10)(11)(12).…”
Section: Introductionmentioning
confidence: 99%